India agrees 'significantly lower' AstraZeneca vaccine price
“The renegotiated price is significantly lower than 200 rupees ($2.75) per dose,” Health Secretary Rajesh Bhushan told a news conference
A healthcare worker prepares to administer a dose of the Oxford University-AstraZeneca vaccine, marketed by the Serum Institute of India (SII) as COVISHIELD, against the coronavirus disease (COVID-19), in Santiago, Dominican Republic February 17, 2021. REUTERS/Ricardo Rojas/File Photo
The Indian government has lowered the price at which it buys AstraZeneca's Covid-19 vaccine doses being produced by the Serum Institute of India (SII), the federal health secretary said on Thursday.
"The renegotiated price is significantly lower than 200 rupees ($2.75) per dose," Health Secretary Rajesh Bhushan told a news conference.
The SII, the world's biggest vaccine maker, has licensed the vaccine from AstraZeneca and Oxford University and markets it as COVISHIELD.
($1 = 72.6360 Indian rupees)
